文献速递青光眼神经眼科

新诊断青光眼患者的二十年结局:死亡与视功能

Twenty-year outcomes in patients with newly diagnosed glaucoma: mortality and visual function.
PubMed 文献 · Br J Ophthalmol · 2018-03-03

该队列研究对436例中68例(16%)新诊断慢性开角型青光眼(COAG)患者随访20年,审计视力与死亡结局,发现约三分之二患者在诊断后20年内死亡,死亡者就诊时平均年龄73.7岁高于存活者63.2岁(P=0.001),存活者中近半数眼视野未恶化。

要点

  • 诊断后20年内约63%的患者死亡,死亡中位时间16年,死亡平均年龄84岁,最常见死因为血管性疾病。
  • 死亡者就诊时平均年龄73.7岁 vs 存活者63.2岁(P=0.001),死亡者最终视力较存活者更差(P<0.001)。
  • 视野分析中48.9%的眼未恶化,28.3%的眼恶化超过两个等级。

核心结论

  • 在该队列中,约三分之二青光眼患者在诊断后20年内死亡,大多数老年青光眼患者诊断后20年实现预防视觉障碍和失明的总体目标是可达到的。

研究设计与样本

  • 对436例中68例(16%)在青光眼病例发现门诊诊断的慢性开角型青光眼(COAG)患者,在诊断后20年从病历审计视力和死亡结局的研究。
  • 死因来自全科医生记录和死亡证明,死亡概率用Kaplan-Meier生存曲线计算,存活者每只眼视野用九级严重程度量表分级。

主要发现

  • 68例中14例(21%)失访,剩余54例中20例(37%)在诊断后20年存活,63%死亡者死亡平均年龄84岁,最常见死因为血管性疾病。
  • 死亡者就诊时平均年龄73.7岁 vs 存活者63.2岁(P=0.001),死亡中位时间16年。
  • 视野分析中48.9%的眼未恶化,28.3%的眼恶化超过两个等级。
  • 死亡者最终视力较存活者更差(P<0.001),死亡者中3例因主要黄斑疾病登记为严重视觉损害,存活者中无登记(P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 68例中14例(21%)失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To determine the mortality within 20 years of diagnosis of chronic open-angle glaucoma (COAG) and visual acuity and visual field progression of a cohort followed for 20 years. METHODS: Twenty years following the diagnosis of COAG in 68 of 436 (16%) patients seen in a glaucoma case-finding clinic, visual and mortality outcomes were audited from medical records. Causes of death were obtained from general practitioner records and death certificates. Probability of death was calculated using a Kaplan-Meier survival curve. The visual field of each eye of survivors was graded using a nine-stage severity scale. Visual outcome was analysed at the 20-year follow-up visit. RESULTS: From 68, 14 (21%) were lost to follow-up. In the remaining 54, 20 (37%) were alive 20 years after diagnosis. Of 63% who died, mean age of death was 84 years, most commonly due to vascular disease. Mean age at presentation of those who died was 73.7 years versus 63.2 years for survivors (P=0.001). The median time to death was 16 years. On visual field analysis, nearly half (48.9%) of eyes did not deteriorate, but 28.3% eyes deteriorated by more than two stages. Those who died had worse final visual acuity than survivors (P<0.001). Three who died were registered severely visually impaired mainly from macular disease, but no survivors were registered (P<0.001). CONCLUSION: In this cohort, approximately two-thirds of patients with glaucoma died within 20 years of diagnosis. In most older patients with glaucoma, the overall goal of preventing visual handicap and blindness is achievable 20 years after diagnosis.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. King C, Sherwin JC, Ratnarajan G, et al. Twenty-year outcomes in patients with newly diagnosed glaucoma: mortality and visual function. Br J Ophthalmol. 2018. PMID: 29502068. doi:10.1136/bjophthalmol-2017-311595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。